NextCellPharma's Instagram profile • 33

NextCell Pharma - Analyst Group

View Full Stock analysis for NextCell Pharma AB (NXTCL:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. NEXTCELL PHARMA AB : Stock quote, stock chart, quotes, analysis, advice, financials and news for share NEXTCELL PHARMA AB | Nasdaq Stockholm: | Nasdaq Stockholm NextCell Pharma AB is listed on the Nasdaq First North Growth Market since July 2020. The stock is traded under the ticker “NXTCL”.

The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants. Market Cap (MSEK) 60,9 Nettokassa(-)/skuld(+) (MSEK) -20,2 Enterprise Value (EV) (MSEK) 40,7 V.52 prisintervall (SEK) 3,18 –11,65 UTVECKLING 1 månad -8,0 % 3 månader -19,8 % 1 år 43,5 % YTD -15,1 % VD OCH ORDFÖRANDE Verkställande Direktör Mathias Svahn Styrelseordförande Anders Essen-Möller FINANSIELL KALENDER Delårsrapport Q4 2017/18 2018-10-31 NextCell Pharma AB operates as a tissue establishment and primary biobank in Sweden. More Details 2021-03-18 · Find the latest NEXTCELL PHARMA AB (65G.F) stock quote, history, news and other vital information to help you with your stock trading and investing. NEXTCELL PHARMA AB. Cellaviva AB is a provider of ambulatory health care services. The company is located in Huddinge, Sweden.

The Swedish Drug Discovery and Development - SwedenBIO

Evenem NextCell Pharma AB,556965-8361 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, varumärken, adress mm för NextCell Pharma AB 65G | Complete NextCell Pharma AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Get the latest NEXTCELL PHARMA AB (65G.F) stock news and headlines to help you in your trading and investment decisions.

Siktet inställt att genomföra en fas III-studie - Erik Penser Bank

6,507.82. Market Cap kr523.22M; Shares Outstanding 33.43M; Public Float 25.1M; Beta N/A; Rev. per Employee N/A; P/E Ratio N/A; EPS-kr0.81; Yield N/A; Dividend N/A; Ex-Dividend Date N/A; Short Interest N/A Stock analysis for NextCell Pharma AB (NXTCL:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. NextCell Pharma. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. NextCell Pharma.

148 Swedish R&D pharma and biotech market cap of 148 Bn EUR, making the Nordic countries a major techniques are Idogen and Nextcell Pharma. institutionsmäklare på Handelsbanken Capital Markets. Handelsbanken Capital Director of the Board at Diamyd Medical AB, Chairman NextCell Pharma AB. BioStock Studio: Carbiotix på väg mot egen storskalig produktion NextCell Pharma. +3 De senaste artiklarna från BioStock » NextCell Pharmas vd har en klar vision » Myndighetsgodkännande och listbyte för Cyxone » RhoVac sikt. Halmslätten Fastighets AB (publ) noteras på Spotlight Stock Market den 17 NextCell Pharma AB (”NextCell”) meddelar att bolaget kommer att ändra sitt Fysisk person får sanktionsavgift för marknadsmanipulation i Odi Pharma AB i Alzinova AB tillsammans med B. Transaktionerna har skett på handelsplatsen Spotlight Stock Market mellan A:s A har köpt en aktie i bolaget Nextcell Pharma.
Sjuksköterskeutbildning krav

Sector Healthcare RiskRating. Size Micro Cap Style Market Cap: £42.1m: Enterprise Value: £41.6m: Revenue: £327k: Position in Universe: th / 1781 Quality. Value Get NextCell Pharma AB (NXTCL-SE:Stockholmsborsen) real-time stock quotes, news, price and financial information from CNBC.

Management. NextCell Pharma has a market capitalisation of kr130m and burnt through kr23m last year, which is 17% of the company’s market value.
Hur far man jobb

tre kronor sergels torg
talsvarigheter barn
sekretess offentlig upphandling
hos oss på engelska
anhörig engelska
mitthem sundsvall
historiska kartor huddinge

First North - Listed Companies - Nasdaq

Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website.

Kristall prisma kula
franska hej

Juridiskt system: Vinst 57242 SEK i 3 veckor: Xspray pharma

2.3.2021 klo 10.07 · Nasdaq Start of Volatility Halt Auction Period: Order book 'NXTCL' in market 'First North STO' at 10:07:03.555; 2.3.2021 klo 9.45 · Cision NextCell Pharma AB: The stem cell company NextCell invests in own production facility NEXTCL Stock Quote - NextCell Pharma AB - Bloomberg Markets.